Mast Cell β-Tryptase Is Enzymatically Stabilized by DNA.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jul 2020
Historique:
received: 24 06 2020
revised: 09 07 2020
accepted: 14 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

Tryptase is a tetrameric serine protease located within the secretory granules of mast cells. In the secretory granules, tryptase is stored in complex with negatively charged heparin proteoglycans and it is known that heparin is essential for stabilizing the enzymatic activity of tryptase. However, recent findings suggest that enzymatically active tryptase also can be found in the nucleus of murine mast cells, but it is not known how the enzmatic activity of tryptase is maintained in the nuclear milieu. Here we hypothesized that tryptase, as well as being stabilized by heparin, can be stabilized by DNA, the rationale being that the anionic charge of DNA could potentially substitute for that of heparin to execute this function. Indeed, we showed that double-stranded DNA preserved the enzymatic activity of human β-tryptase with a similar efficiency as heparin. In contrast, single-stranded DNA did not have this capacity. We also demonstrated that DNA fragments down to 400 base pairs have tryptase-stabilizing effects equal to that of intact DNA. Further, we showed that DNA-stabilized tryptase was more efficient in degrading nuclear core histones than heparin-stabilized enzyme. Finally, we demonstrated that tryptase, similar to its nuclear localization in murine mast cells, is found within the nucleus of primary human skin mast cells. Altogether, these finding reveal a hitherto unknown mechanism for the stabilization of mast cell tryptase, and these findings can have an important impact on our understanding of how tryptase regulates nuclear events.

Identifiants

pubmed: 32709152
pii: ijms21145065
doi: 10.3390/ijms21145065
pmc: PMC7404274
pii:
doi:

Substances chimiques

DNA 9007-49-2
Tryptases EC 3.4.21.59

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Vetenskapsrådet
ID : 2017-00760
Organisme : Cancerfonden
ID : 16 0680
Organisme : Knut och Alice Wallenbergs Stiftelse
ID : 2017.0022
Organisme : Barncancerfonden
ID : PR2017-0069
Organisme : Hjärtlungfonden
ID : 20180193

Références

J Biol Chem. 2014 Mar 14;289(11):7682-90
pubmed: 24478313
J Leukoc Biol. 2004 Feb;75(2):244-52
pubmed: 14634065
PLoS One. 2013;8(1):e52980
pubmed: 23326369
Immunity. 2012 Jul 27;37(1):25-33
pubmed: 22840841
J Biol Chem. 2001 Nov 16;276(46):42774-81
pubmed: 11533057
Pigment Cell Melanoma Res. 2020 Jul;33(4):579-590
pubmed: 31894627
Adv Immunol. 2007;95:167-255
pubmed: 17869614
J Mol Biol. 2005 Jan 7;345(1):129-39
pubmed: 15567416
Biol Chem. 2010 Aug;391(8):923-35
pubmed: 20536394
Int J Mol Sci. 2019 Oct 17;20(20):
pubmed: 31627390
Cell Death Dis. 2019 Sep 10;10(9):659
pubmed: 31506436
J Biol Chem. 1986 Jun 5;261(16):7372-9
pubmed: 3519608
Blood. 2010 Jun 17;115(24):4981-90
pubmed: 20233968
Cell. 2008 Oct 17;135(2):284-94
pubmed: 18957203
Biochemistry. 2000 Oct 24;39(42):13068-77
pubmed: 11041873
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):10984-91
pubmed: 10500112
Nature. 1998 Mar 19;392(6673):306-11
pubmed: 9521329
Cancer Res. 2015 Jul 1;75(13):2653-62
pubmed: 26071254
J Biol Chem. 2004 Sep 24;279(39):40897-905
pubmed: 15231821
Nature. 1999 Aug 19;400(6746):773-6
pubmed: 10466727
Nat Rev Immunol. 2014 Jul;14(7):478-94
pubmed: 24903914
FEBS J. 2006 May;273(9):1871-95
pubmed: 16640553
J Allergy Clin Immunol. 2017 Aug;140(2):474-485
pubmed: 28108335

Auteurs

Sultan Alanazi (S)

Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.

Mirjana Grujic (M)

Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.

Maria Lampinen (M)

Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.
Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.

Ola Rollman (O)

Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.

Christian P Sommerhoff (CP)

Institute of Laboratory Medicine, University Hospital, 80539 LMU Munich, Germany.

Gunnar Pejler (G)

Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.
Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, 756 51 Uppsala, Sweden.

Fabio Rabelo Melo (FR)

Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH